Certified
« back to search results

TAW-93085  /  Pharmaceutical Systems (Franklin Lakes, NJ)

Petitioner Type: State
Impact Date: 08/08/2016
Filed Date: 08/21/2017
Most Recent Update: 12/20/2017
Determination Date: 12/20/2017
Expiration Date: 12/20/2019

DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-93,085

PHARMACEUTICAL SYSTEMS
BD MEDICAL DIVISION
RESEARCH & DEVELOPMENT DEPARTMENT
CUSTOMER SERVICE DEPARTMENT
INCLUDING ON-SITE LEASED WORKERS FROM
THE ACT 1 GROUP, INC. (D/B/A AGILE 1)
FRANKLIN LAKES, NEW JERSEY

Certification Regarding Eligibility
To Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended ("Act"), 19 U.S.C. § 2273, the Department of Labor herein
presents the results of an investigation regarding certification
of eligibility to apply for worker adjustment assistance.
The group eligibility requirements for workers of a firm
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), are
satisfied if the following criteria are met:
(1) a significant number or proportion of the workers
in such workers' firm have become totally or partially
separated, or are threatened to become totally or
partially separated;
(2)(B)(i)(I) there has been a shift by the workers'
firm to a foreign country in the production of articles
or supply of services like or directly competitive with
those produced/supplied by the workers' firm; OR
(II) there has been an acquisition from a
foreign country by the workers' firm of
articles/services that are like or directly
competitive with those produced/supplied by
the workers' firm; AND
(ii) the shift/acquisition must have contributed
importantly to the workers' separation or
threat of separation.

The investigation was initiated in response to a petition
filed on August 21, 2017 by the state workforce office on behalf
of workers of Pharmaceutical Systems, BD Medical Division,
Research & Development Department, Customer Service Department,
Franklin Lakes, New Jersey (collectively referred to as
"Pharmaceutical Systems-R&D/Customer Service"). The workers of
Pharmaceutical Systems-R&D/Customer Service are engaged in
activities related to supplying research & development services
(Research & Development Department) and customer service (Customer
Service Department) of self-administered injection systems
(SAIS).
The subject worker groups include on-site leased workers from
The Act 1 Group, Inc. (d/b/a Agile 1).
During the course of the investigation, information was
collected from the workers' firm.
Section 222(a)(1) has been met because a significant number
or proportion of the workers in Pharmaceutical Systems-
R&D/Customer Service have become totally or partially separated,
or are threatened to become totally or partially separated.
Section 222(a)(2)(B) has been met because the workers' firm
has shifted to a foreign country the supply of services like or
directly competitive with the services supplied by the subject
workers which contributed importantly to worker group separations
at Pharmaceutical Systems-R&D/Customer Service.
Conclusion
After careful review of the facts obtained in the
investigation, I determine that workers of Pharmaceutical Systems-
R&D/Customer Service, who are engaged in activities related to the
supply of research & development services and customer services,
meet the worker group certification criteria under Section 222(a)
of the Act, 19 U.S.C. § 2272(a). In accordance with Section 223 of
the Act, 19 U.S.C. § 2273, I make the following certification:
"All workers of Pharmaceutical Systems, BD Medical Division,
Research & Development Department, Customer Service
Department, including on-site leased workers from The Act 1
Group, Inc. (d/b/a Agile 1), Franklin Lakes, New Jersey, who
became totally or partially separated from employment on or
after August 8, 2016 through two years from the date of
certification, and all workers in the group threatened with
total or partial separation from employment on the date of
certification through two years from the date of
certification, are eligible to apply for adjustment
assistance under Chapter 2 of Title II of the Trade Act of
1974, as amended."
Signed in Washington, D.C. this 20th day of December 2017.

/s/Del Min Amy Chen
______________________________
DEL MIN AMY CHEN
Certifying Officer, Office of
Trade Adjustment Assistance